cipaglucosidase alfa-atga 105 MG Injection [Pombiliti]

RxCUI: 2667446
RxNorm name: cipaglucosidase alfa-atga 105 MG Injection [Pombiliti]
Display name: cipaglucosidase alfa-atga 105 MG Injection [Pombiliti]
Full name: cipaglucosidase alfa-atga 105 MG Injection [Pombiliti]
Term type: SBD
Status: DailyMed mapping
Updated: 2026-06-04 23:39:23

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLA	Proprietary name	Proper name	License type	Status	Latest source
761204	Pombiliti	cipaglucosidase alfa-atga	351(a)	Rx	2026-08-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
POMBILITI ATGA	CIPAGLUCOSIDASE ALFA-ATGA	AMICUS THERAPEUTICS US, LLC	d77aa596-910d-516b-e053-2995a90a0839	2026-08-12	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 2667446

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
d77aa596-910d-516b-e053-2995a90a0839	POMBILITI 105 MG Injection [PSN] · cipaglucosidase alfa-atga 105 MG Injection [Pombiliti] [SBD] · Pombiliti 105 MG Injection [SY]	3	5	These highlights do not include all the information needed to use POMBILITI ® safely and effectively. See full prescribing information for POMBILITI. POMBILITI (cipaglucosidase alfa-atga) for injection, for intravenous use Initial U.S. Approval: 2023	20241127